Yesterday, a panel from the Fifth Circuit, comprised of Judges Jennifer Walker Elrod, James C. Ho, and Cory T. Wilson, delivered a ruling on the accessibility of the common abortion medication mifepristone. The all-Republican appointee panel ruled favorably for the plaintiffs aiming to overturn the U.S. Food and Drug Administration’s long-standing approval of the medication. Although the majority decision did not completely reverse the FDA’s approval, it did reinstate restrictions on access to mifepristone. This restricts patients’ ability to obtain the drug via mail and telehealth visits with prescribers. It is important to note that the order is stayed pending the resolution of any petition for Supreme Court review, which means the relaxed access will remain in effect until that time.
Citing safety concerns as their major grounds for the ruling, the majority suggested that the FDA fell short in analyzing how loosening mifepristone’s safety restrictions could alter the risk profile for users. They criticized the FDA’s failure to consider the combined effect of removing several significant safeguards simultaneously, along with the agency’s lack of evidence that mifepristone could be safely used without in-person prescription and dispensing.
In a controversial move, Judge James C. Ho, in his concurrence/dissent, advocated for a complete revocation of mifepristone’s approval, despite the drug being on the market for over two decades. His argument proposed that anti-abortion doctors have the standing to challenge the drug’s approval, citing what he termed “aesthetic injury.” His statement spurred debate as some observers argued that he might not be willing to apply the same argument about standing in a gun case.
Recent developments have again highlighted the ideological leaning of some judges who seem to be more committed to advancing conservative policy goals under the veneer of neutrality. As observers continue to unpack the various implications of the Fifth Circuit’s ruling, it’s clear that this is another critical chapter in the ongoing debate surrounding reproductive rights.